Clinical Trial Update: The 3DKnee™ System: A Post-Market Study [Phase 4]

View source ↗

Summary

Phase 4 post-market study results for the 3DKnee System from Encore Medical, evaluating its use in osteoarthritis and related knee conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Osteoarthritis
• Post-traumatic Arthritis
• Rheumatoid Arthritis
• Varus Deformity

Drugs mentioned

• 3DKnee System

Snippet

Sponsor: Encore Medical, L.P. | Conditions: Osteoarthritis, Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2011-03-02